Drug Profile


Alternative Names: AR 726; Aroplatin; Liposomal NDDP; NDDP; Platar

Latest Information Update: 11 Oct 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Dainippon Sumitomo Pharma; University of Texas M. D. Anderson Cancer Center
  • Developer Agenus
  • Class Antineoplastics; Platinum complexes
  • Mechanism of Action Alkylating agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Colorectal cancer; Non-Hodgkin's lymphoma; Solid tumours

Most Recent Events

  • 24 Sep 2003 Phase II study data have been added to the adverse events and Cancer therapeutic trials sections ,
  • 24 Sep 2003 Antigenics has completed a phase II monotherapy trial in metastatic colorectal cancer patients in the USA
  • 18 Jul 2002 Phase-II clinical trials in Colorectal cancer in USA (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top